← FDA DRUG APPROVALS

FDA NDA · NDA015417

MEPROBAMATE

Sponsor: WEST WARD

APPLICATION
NDA015417
TYPE
NDA
ORIGINAL APPROVAL
1964-12-12
LATEST ACTION
1981-02-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

MEPROBAMATEDiscontinued
MEPROBAMATE 200MG · TABLET · ORAL
MEPROBAMATEDiscontinued
MEPROBAMATE 400MG · TABLET · ORAL

Approval history

1981-02-11Labeling · Supplement 12 · standardAP
1977-08-26Labeling · Supplement 10 · standardAP
1964-12-12Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →